An updated review on transdermal drug delivery systems

Transdermal drug delivery systems (TDDS), also known as “patches,” are dosage forms designed to deliver a therapeutically effective amount of drug across a patient’s skin. In order to deliver therapeutic agents through the human skin for systemic effects, the comprehensive morphological, biophysical and physicochemical properties of the skin are to be considered. Transdermal delivery provides a leading edge over injectables and oral routes by increasing patient compliance and avoiding first pass metabolism respectively. Transdermal delivery not only provides controlled, constant administration of the drug, but also allows continuous input of drugs with short biological half-lives and eliminates pulsed entry into systemic circulation, which often causes undesirable side effects. The TDDS review articles provide valuable information regarding the transdermal drug delivery systems and its evaluation process details as a ready reference for the research scientist who is involved in TDDS. With the advancement in technology Pharma industries have trendified all its resources. Earlier we use convectional dosage form but now we use novel drug delivery system. One of greatest innovation of novel drug delivery is transdermal patch. The advantage of transdermal drug delivery system is that it is painless technique of administration of drugs.

[1]  Russell O. Potts,et al.  Evidence that Oleic Acid Exists in a Separate Phase Within Stratum Corneum Lipids , 1991, Pharmaceutical Research.

[2]  J. Wiechers Model systems in iontophoresis--transport efficacy. , 1992 .

[3]  B. Aungst Structure/Effect Studies of Fatty Acid Isomers as Skin Penetration Enhancers and Skin Irritants , 1989, Pharmaceutical Research.

[4]  Russell O. Potts,et al.  Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans , 1995 .

[5]  D. Monti,et al.  Enhancement of transdermal penetration of dapiprazole through hairless mouse skin , 1991 .

[6]  A. El‐Kattan,et al.  Enhancement of transdermal drug delivery: chemical and physical approaches. , 2000, Critical reviews in therapeutic drug carrier systems.

[7]  N. Chandrashekar,et al.  Physicochemical and Pharmacokinetic Parameters in Drug Selection and Loading for Transdermal Drug Delivery , 2008, Indian journal of pharmaceutical sciences.

[8]  S. Mutalik,et al.  Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation , 2003, AAPS PharmSciTech.

[9]  M.Karthikeyan,et al.  Transdermal Drug Delivery System: A Review , 2010 .

[10]  M. Okumura,et al.  Re: Topical application of glibenclamide lowers blood glucose levels in rats. , 1988, Diabetes research and clinical practice.

[11]  Taravat Ghafourian,et al.  The effect of penetration enhancers on drug delivery through skin: a QSAR study. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A. Ahad,et al.  Status of terpenes as skin penetration enhancers. , 2007, Drug discovery today.

[13]  S. Scheindlin Transdermal drug delivery: PAST, PRESENT, FUTURE. , 2004, Molecular interventions.

[14]  Saurabh Sharma,et al.  TRANSDERMAL DRUG DELIVERY SYSTEM: REVIEW , 2012 .

[15]  S. Talegaonkar,et al.  DESIGN AND DEVELOPMENT OF O/W NANOEMULSION FOR THE TRANSDERMAL DELIVERY OF ONDANSETRON , 2011 .

[16]  S. Raghuraman,et al.  Design And Evaluation Of Propranolol Hydrochloride Buccal Films , 2002 .

[17]  J. Hadgraft,et al.  Microviscosity and drug release from topical gel formulations , 1986, Pharmaceutical Research.

[18]  D. D. Kim,et al.  Formulation of a reservoir-type testosterone transdermal delivery system. , 2001, International journal of pharmaceutics.

[19]  S. Chan,et al.  Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. , 2002, Journal of pharmaceutical sciences.

[20]  Z. A. Bhat,et al.  A Review: Transdermal Drug Delivery System: A Tool For Novel Drug Delivery System , 2011 .

[21]  T. Sivakumar,et al.  Design and evaluation of transdermal drug delivery of ketotifen fumarate , 2010 .

[22]  T. Nagai,et al.  Percutaneous absorption enhancing effect and skin irritation of monocyclic monoterpenes. , 1990, Drug design and delivery.

[23]  Vinod Patidar,et al.  Formulation and Evaluation of Transdermal Drug Delivery System of Clopidogrel Bisulfate , 2011 .

[24]  S A Jones,et al.  Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[25]  N. Satish,et al.  Development and evaluation of transdermal patches of Colchicine , 2012 .

[26]  AN OVERVIEW OF DIABETES MELLITUS , 2003 .

[27]  Bharat Parashar,et al.  Blooming Pharma Industry with Transdermal Drug Delivery System , 2012, Indo Global Journal of Pharmaceutical Sciences.

[28]  N. Udupa,et al.  Design and evaluation of matrix type and membrane controlled transdermal delivery systems of nicotine suitable for use in smoking cessation , 2006 .

[29]  G. Shingade REVIEW ON: RECENT TREND ON TRANSDERMAL DRUG DELIVERY SYSTEM , 2012 .

[30]  Adrian C. Williams,et al.  Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement , 2004, Pharmaceutical Research.

[31]  M. Aqil,et al.  Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  M. Karthikeyan,et al.  Transdermal Drug Delivery System: A Review , 2010 .

[33]  V. John,et al.  Pharmacokinetic Characterisation of Transdermal Delivery Systems , 1994, Clinical pharmacokinetics.

[34]  S. Chaudhari,et al.  PERMEATION STUDIES OF PIOGLITAZONE HCL FROM FICUS CARICA FRUIT MUCILAGE MATRIX TRANSDERMAL PATCHES , 2012 .

[35]  K. Tripathi,et al.  Effect of Penetration Enhancers on the in Vitro Transport of Ephedrine Through Rat Skin and Human Epidermis from Matrix Based Transdermal Formulations , 1993 .

[36]  M. Singh,et al.  Transdermal Drug Delivery Systems with major emphasis on Transdermal patches : A Review , 2016 .

[37]  V. Sinha,et al.  Permeation Enhancers for Transdermal Drug Delivery , 2000, Drug development and industrial pharmacy.